Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused ‘out of an abundance of caution’
This two-pronged approach was tested on lab monkeys and guinea pigs.
This method helps block pain signals better than low-frequency treatments for chronic back and leg pain.
‘This is potentially a lifesaving therapy,’ researcher says.
A new experimental DNA-based vaccine against the Zika virus has already begun in human safety trials.
The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.
According to this randomized trial, there was limited clinical benefit for patients with brain metastases after receiving whole brain radiotherapy.